474 related articles for article (PubMed ID: 11134627)
1. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum.
Cartmell J; Salhoff CR; Perry KW; Monn JA; Schoepp DD
Brain Res; 2000 Dec; 887(2):378-84. PubMed ID: 11134627
[TBL] [Abstract][Full Text] [Related]
2. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat.
Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
J Neurochem; 2000 Sep; 75(3):1147-54. PubMed ID: 10936197
[TBL] [Abstract][Full Text] [Related]
3. Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade.
Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
Neuropharmacology; 2001 Jun; 40(7):847-55. PubMed ID: 11378155
[TBL] [Abstract][Full Text] [Related]
4. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
Batool F; Hasnat A; Haleem MA; Haleem DJ
Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
[TBL] [Abstract][Full Text] [Related]
5. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.
Lorrain DS; Baccei CS; Bristow LJ; Anderson JJ; Varney MA
Neuroscience; 2003; 117(3):697-706. PubMed ID: 12617973
[TBL] [Abstract][Full Text] [Related]
6. Effects of a novel mGlu₂/₃ receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluid.
Lowe S; Dean R; Ackermann B; Jackson K; Natanegara F; Anderson S; Eckstein J; Yuen E; Ayan-Oshodi M; Ho M; McKinzie D; Perry K; Svensson K
Psychopharmacology (Berl); 2012 Feb; 219(4):959-70. PubMed ID: 21847569
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine.
Cartmell J; Monn JA; Schoepp DD
Psychopharmacology (Berl); 2000 Mar; 148(4):423-9. PubMed ID: 10928316
[TBL] [Abstract][Full Text] [Related]
8. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell.
Greenslade RG; Mitchell SN
Neuropharmacology; 2004 Jul; 47(1):1-8. PubMed ID: 15165829
[TBL] [Abstract][Full Text] [Related]
9. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
Gray AM; Connick JH
Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of 17 beta-estradiol and lithium on ovariectomized rat brain biogenic amines metabolism.
Morissette M; Paolo TD
J Psychiatr Res; 1996; 30(2):95-107. PubMed ID: 8816304
[TBL] [Abstract][Full Text] [Related]
11. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
Cartmell J; Monn JA; Schoepp DD
J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
[TBL] [Abstract][Full Text] [Related]
12. Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.
Hertel P; Nomikos GG; Iurlo M; Svensson TH
Psychopharmacology (Berl); 1996 Mar; 124(1-2):74-86. PubMed ID: 8935802
[TBL] [Abstract][Full Text] [Related]
13. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.
Abekawa T; Ohmori T; Koyama T
Brain Res; 1994 Apr; 643(1-2):276-81. PubMed ID: 7518327
[TBL] [Abstract][Full Text] [Related]
14. Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge.
Fell MJ; Katner JS; Johnson BG; Khilevich A; Schkeryantz JM; Perry KW; Svensson KA
Neuropharmacology; 2010 Mar; 58(3):632-9. PubMed ID: 19951716
[TBL] [Abstract][Full Text] [Related]
15. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
Invernizzi R; Morali F; Pozzi L; Samanin R
Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
[TBL] [Abstract][Full Text] [Related]
17. The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats.
Swanson CJ; Schoepp DD
J Pharmacol Exp Ther; 2002 Dec; 303(3):919-27. PubMed ID: 12438510
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
Rivest R; Marsden CA
Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
[TBL] [Abstract][Full Text] [Related]
19. Acute administration of clozapine, thioridazine and metoclopramide increases extracellular DOPAC and decreases extracellular 5-HIAA, measured in the nucleus accumbens and striatum of the rat using in vivo voltammetry.
Maidment NT; Marsden CA
Neuropharmacology; 1987; 26(2-3):187-93. PubMed ID: 2438582
[TBL] [Abstract][Full Text] [Related]
20. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover.
Ballarín M; Carceller A; Guitart X
Br J Pharmacol; 1994 Oct; 113(2):425-30. PubMed ID: 7530571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]